The accelerating pace of U.S. FDA approvals for cell and gene therapies is “great for the field and great news for the patients,” but questions remain over commercialization, with “costs remaining ...
"We're going to bring together people from the alternative medicine field with research methodologists, to try to see if there are new kinds of methodologies we can develop that are more appropriate ...